Rubicon Organics Inc (V:ROMJ) — Market Cap & Net Worth
Market Cap & Net Worth: Rubicon Organics Inc (ROMJ)
Rubicon Organics Inc (V:ROMJ) has a market capitalization of $23.47 Million (CA$32.44 Million) as of September 19, 2026. Listed on the V stock exchange, this Canada-based company holds position #24690 globally and #947 in its home market, demonstrating a -1.03% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Rubicon Organics Inc's stock price CA$0.48 by its total outstanding shares 67578916 (67.58 Million). Also see ROMJ asset base for a full breakdown of the balance sheet.
Rubicon Organics Inc Market Cap History: 2018 to 2026
Rubicon Organics Inc's market capitalization history from 2018 to 2026. Data shows change from $92.39 Million to $23.47 Million (-21.39% CAGR). Also see Rubicon Organics Inc operating cash flow efficiency for how efficiently the company converts equity into cash flow.
Rubicon Organics Inc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Rubicon Organics Inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Check latest Rubicon Organics Inc stock price today for real-time trading data and today's change.
Latest Price to Sales (P/S) Ratio
0.39x
Rubicon Organics Inc's market cap is 0.39 times its annual revenue
Latest Price to Earnings (P/E) Ratio
22.33x
Rubicon Organics Inc's market cap is 22.33 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2018 | $92.39 Million | $2.03 Million | -$29.88 Million | 45.54x | N/A |
| 2019 | $89.95 Million | $454.04K | -$14.27 Million | 198.11x | N/A |
| 2020 | $176.97 Million | $9.39 Million | -$14.98 Million | 18.85x | N/A |
| 2021 | $90.44 Million | $22.61 Million | -$14.52 Million | 4.00x | N/A |
| 2022 | $37.64 Million | $35.52 Million | -$3.86 Million | 1.06x | N/A |
| 2023 | $24.44 Million | $40.12 Million | -$1.82 Million | 0.61x | N/A |
| 2024 | $23.47 Million | $48.70 Million | -$2.56 Million | 0.48x | N/A |
| 2025 | $23.47 Million | $59.45 Million | $1.05 Million | 0.39x | 22.33x |
Competitor Companies of ROMJ by Market Capitalization
Companies near Rubicon Organics Inc in the global market cap rankings as of September 19, 2026. Review how tangible is Rubicon Organics Inc's equity to assess the quality of the company's equity after excluding intangible assets.
Key companies related to Rubicon Organics Inc by market ranking:
- Takeda Pharmaceutical Co Ltd ADR (NYSE:TAK): Ranked #518 globally with a market cap of $52.60 Billion USD.
- GALDERMA GROUP AG (NYSE:GALDY): Ranked #613 globally with a market cap of $44.92 Billion USD.
- Takeda Pharmaceutical Company Limited (F:TKDA): Ranked #635 globally with a market cap of $43.60 Billion USD ( €37.29 Billion EUR).
- Jiangsu Hengrui Medicine Co Ltd (SHG:600276): Ranked #670 globally with a market cap of $40.99 Billion USD ( CN¥280.10 Billion CNY).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #518 | Takeda Pharmaceutical Co Ltd ADR | NYSE:TAK | $52.60 Billion | $16.65 |
| #613 | GALDERMA GROUP AG | NYSE:GALDY | $44.92 Billion | $38.53 |
| #635 | Takeda Pharmaceutical Company Limited | F:TKDA | $43.60 Billion | €16.90 |
| #670 | Jiangsu Hengrui Medicine Co Ltd | SHG:600276 | $40.99 Billion | CN¥43.91 |
Rubicon Organics Inc Historical Marketcap From 2018 to 2026
Between 2018 and today, Rubicon Organics Inc's market cap moved from $92.39 Million to $ 23.47 Million, with a yearly change of -21.39%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | CA$23.47 Million | 0.00% |
| 2025 | CA$23.47 Million | 0.00% |
| 2024 | CA$23.47 Million | -4.00% |
| 2023 | CA$24.44 Million | -35.06% |
| 2022 | CA$37.64 Million | -58.38% |
| 2021 | CA$90.44 Million | -48.90% |
| 2020 | CA$176.97 Million | +96.74% |
| 2019 | CA$89.95 Million | -2.65% |
| 2018 | CA$92.39 Million | -- |
End of Day Market Cap According to Different Sources
On Sep 19th, 2026 the market cap of Rubicon Organics Inc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $23.47 Million USD |
| MoneyControl | $23.47 Million USD |
| MarketWatch | $23.47 Million USD |
| marketcap.company | $23.47 Million USD |
| Reuters | $23.47 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Rubicon Organics Inc
Rubicon Organics Inc., together with its subsidiaries, engages in the production, processing, and sale of organic cannabis for the recreational and medical-use markets in Canada and internationally. The company offers cannabis products in dried flower, pre-rolls, concentrates, gummies, capsules, edibles, vapes, topicals, relief sticks, and oils. It sells its products under the Simply Bare Organic… Read more